Klin Farmakol Farm. 2017;31(3):7-8 | DOI: 10.36290/far.2017.015

Could pregabaline be effective medication in treatment of depressive disorder?

Miroslav Sekot
Psychiatrická klinika 1. LF VFN a UK, Praha

Pregabalin belongs to a group of antiepileptics and it is indicated for the treatment of generalized anxiety disorder and neuropaticpain. Although the antidepressant effect of pregabalin has not been proven, pregabalin can positively affect the mood of patientswith pain syndromes of various etiologies. Two case studies of pregabalin treatment in patients with depressive symptomatologyare described in this article.

Keywords: pregabalin, generalized anxiety disorder, depression, pain, bendoziazepines

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sekot M. Could pregabaline be effective medication in treatment of depressive disorder? Klin Farmakol Farm. 2017;31(3):7-8. doi: 10.36290/far.2017.015.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hajda M, Kamarádová D, Praško JP. Léčba generalizované úzkostné poruchy pomoci pregabalinu Psychiatr. Praxi 2015; 16(3): 101-104.
    2. Doubek P, Anders M. Generalizovaná úzkostná porucha. Maxdorf 2013; 7-9.
    3. Kawalec P, Cierniak A Pilc A, Nowak G: Pregabalin for the treatment of social anxiety disorder. Expert Opin Investig Drugs 2015; 24(4): 585-594. Go to original source... Go to PubMed...
    4. Kmoch V. Pacient s generalizovanou úzkostí a jeho závislost na zolpidemu - léčba pregabalinem a motivační rozhovory. Psychiatr. Praxi 2015; 16(2): 60-63.
    5. Tkáč J. Pregabalin v léčebě generalizované úzkosti a lékové závislosti na alprazolamu. Psychiatr. praxi 2015; 16(1): 24-26.
    6. Bednařík J, Ambler Z. Léčba diabetické neuropatie. Neurol. praxi 2012; 13(Suppl. E): 25-30.
    7. Arnold LM, Sarzi-Puttini P, Arsenault P, et al. Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.J Rheumatol. 2015; 42(7): 1237-1244. Go to original source... Go to PubMed...
    8. CaboMeseuger A, Cerdá-OlmedoG, Trillo-Mata. Fibromyalgia: Prevalence, Epidemiologic profiles and economic costs. Med Clin (Barc). 2017 Jul 19, pii: S0025-7753(17)30477-3. Go to original source...
    9. Hall TD, Shah S, Feberwee HM, Vandermost M, King MA. Changes in mood, depression and suicidal ideation after commencing pregabalinfor neuropathic pain. Aust Fam Psychician 2014; 43(10): 705-708.
    10. Kalinin W. Suicidality and antiepileptic drugs? Is there a link? Drug Saf. 2007; 30: 123-142. Go to original source...
    11. Arana A, Wenworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Eng J Med 2010; 363: 542-551. Go to original source...
    12. Kustermann A, Möbius C, Oberstein T, Müller HH, Kornhuber J. Depression and attempted suicide under pregabalin therapy Annals of General Psychiatry 2014; 13: 37. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.